Kintara Therapeutics Inc. Recorded Big Gain
Wed, May 03, 2023 at 07:26 PM
Kintara Therapeutics Inc. (KTRA:NASDAQ) rocketted at $4.36, a gain of 47.3%. On Wed, May 03, 2023, KTRA:NASDAQ touched a New 2-Week High of $4.36. The stock got featured on our News Catalysts scanner on Mon, May 01, 2023 at 09:18 AM in the 'MISCELLANEOUS' category. From Wed, Apr 19, 2023, the stock recorded 50.00% Up Days and 36.36% Green Days
About Kintara Therapeutics Inc. (KTRA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- ImmunoGen, Inc. (IMGN:NASDAQ), 135.77%
- Aptorum Group Limited (APM:NASDAQ), 104.64%
- Harbor Custom Development Inc. (HCDI:NASDAQ), 90.25%
- Aceragen Inc Com (ACGN:NASDAQ), 84.02%
- GD Culture Group Ltd Com (New) (GDC:NASDAQ), 69.71%
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 59.97%
- Dunxin Financial Holdings Limited (DXF:NYSEMKT), 56.1%
- Sentage Holdings Inc. (SNTG:NASDAQ), 55.51%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 47.3%
- Akili Inc. (AKLI:NASDAQ), 46.79%